HOME >> MEDICINE >> NEWS
New hope in cancer vaccines emerges as novel therapies are developed and tested

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays. And for the first time, the prospect of eradicating a specific cancer through vaccination is possible. The newly approved human papillomavirus (HPV) vaccine is designed to curb the 230,000 worldwide deaths due to cervical cancer, which is caused solely by HPV. And the hepatitis B virus, responsible for 70 percent of all liver cancer deaths, is also preventable with a vaccine.

Cancer researchers are working on the next era of vaccines designed to treat cancer that has already developed. These vaccines don't rev up the human immune system to attack an invading microbe, but prime the system to go after a unique biological tag found only on tumor cells.

For example, brain cancer researchers at The University of Texas M. D. Anderson Cancer Center are testing an experimental vaccine that homes to a protein studding the surface of glioblastoma cancer cells. It tricks the body into thinking this protein is foreign and infectious, which alerts killer immune cells. The same kind of strategy is producing very promising results in clinical trials at M. D. Anderson of vaccines for advanced myeloid leukemia as well as other forms of leukemia, aggressive lymphoma and melanoma.

Because of the preliminary nature of therapeutic cancer vaccines - none has yet been approved for use anywhere in the world - researchers can only describe their findings as "promising." But their hope in the therapy is clear. In fact, several M. D. Anderson vaccine clinical trials have shown strong anti-tumor activity and one produced the first clinical demonstration that a vaccine could produce complete molecular remission - meaning, no biological evidence of cancer remained in some treated patients.

This wealth of cancer vaccine research at M. D. Anderson - possibly the most varied and advanced
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
4-Aug-2006


Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. Stomach cancer rate set to fall further 25 percent over next decade
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
7. Pathway links inflammation, angiogenesis and breast cancer
8. Using MRI for diagnosis could help prevent breast cancer progression
9. Electric fields have potential as a cancer treatment
10. Shining light on pancreatic cancer
11. Method shows promise for early detection of pancreatic cancer

Post Your Comments:
(Date:5/23/2013)... 2013 Cheap Concert Tickets announces that ... 2013 at stadiums throughout North America. This well known ... McCartney concert tickets to help McCartney fans see Sir Paul ... Tickets, states that she is also offering the customer appreciation ... Being a baby boomer, she is also a huge McCartney ...
(Date:5/23/2013)... News) -- Schools should ensure that kids get ... day to support their health and boost performance ... Although previous studies show 60 minutes of ... development, it,s estimated that only about 50 percent ... according to the report from the Institute of ...
(Date:5/23/2013)... 23 (HealthDay News) -- Symptoms of borderline personality ... complicating diagnosis and treatment. But researchers in Canada ... be unique to borderline personality disorder: a tendency ... , "They have difficulty processing facial emotions and ... face," said Anthony Ruocco, a clinical neuropsychologist and ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay ... teeth as badly as methamphetamine or crack cocaine, a ... with ,meth mouth, or ,coke mouth, it is startling ... or less the same," said Dr. Mohamed Bassiouny, a ... of Dentistry in Philadelphia. Methamphetamine, crack cocaine and ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Although a ... reverse the thinking and memory problems associated with ... they have been unable to duplicate those findings. ... serious implications for patient safety since the drug ... side effects, such as major blood-lipid abnormalities, pancreatitis, ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
(Date:5/23/2013)... May 23, 2013 Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a company overview at the Deutsche ... Thursday, May 30, 2013 at 8:40 a.m. ET in ... webcast of the presentation will be available on the "Investors ... .  A replay will be available on the Isis Web ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Cardinal Health Selects Datameer for Healthcare Data Discovery 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: